Novavax, Inc.
NVAX
$7.93
-$0.02-0.25%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 54.58% | 7.25% | 179.93% | 49.80% | 2.12% |
| Total Depreciation and Amortization | 15.96% | 12.18% | 10.58% | 34.32% | 49.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -238.60% | -54.91% | -49.55% | -55.92% | -58.92% |
| Change in Net Operating Assets | 1.91% | -219.07% | 139.65% | 142.50% | -20.49% |
| Cash from Operations | 2.05% | -265.18% | 282.78% | 74.34% | -50.05% |
| Capital Expenditure | 78.14% | 92.44% | 58.77% | 65.26% | 61.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -19,441.42% | 14,384.98% | -45,784.86% | 90.10% | -124.92% |
| Cash from Investing | 1,686.33% | 273.52% | -4,691.19% | 69.22% | 58.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -18.84% | -129.12% | 19.21% | 99.90% | 95.14% |
| Issuance of Common Stock | -- | -99.79% | 317.50% | 1,163.72% | 47.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 82.85% | 100.00% |
| Cash from Financing | -103.41% | -100.05% | 320.99% | 101.66% | -47.56% |
| Foreign Exchange rate Adjustments | -467.40% | -35.51% | 74.84% | 64.70% | -31.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 47.55% | -172.07% | 267.75% | 87.66% | -247.88% |
